[go: up one dir, main page]

FR2880807B1 - PHARMACEUTICAL COMPOSITION INJECTABLE - Google Patents

PHARMACEUTICAL COMPOSITION INJECTABLE

Info

Publication number
FR2880807B1
FR2880807B1 FR0500532A FR0500532A FR2880807B1 FR 2880807 B1 FR2880807 B1 FR 2880807B1 FR 0500532 A FR0500532 A FR 0500532A FR 0500532 A FR0500532 A FR 0500532A FR 2880807 B1 FR2880807 B1 FR 2880807B1
Authority
FR
France
Prior art keywords
pharmaceutical composition
composition injectable
injectable
pharmaceutical
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0500532A
Other languages
French (fr)
Other versions
FR2880807A1 (en
Inventor
Veronique Zanardo
Christophe Smati
Alain Botella
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratoire Aguettant SAS
Original Assignee
Laboratoire Aguettant SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoire Aguettant SAS filed Critical Laboratoire Aguettant SAS
Priority to FR0500532A priority Critical patent/FR2880807B1/en
Priority to PCT/FR2006/000095 priority patent/WO2006077309A1/en
Publication of FR2880807A1 publication Critical patent/FR2880807A1/en
Application granted granted Critical
Publication of FR2880807B1 publication Critical patent/FR2880807B1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/095—Oxytocins; Vasopressins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FR0500532A 2005-01-19 2005-01-19 PHARMACEUTICAL COMPOSITION INJECTABLE Expired - Fee Related FR2880807B1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FR0500532A FR2880807B1 (en) 2005-01-19 2005-01-19 PHARMACEUTICAL COMPOSITION INJECTABLE
PCT/FR2006/000095 WO2006077309A1 (en) 2005-01-19 2006-01-16 Injectable pharmaceutical composition containing a catecholamine and a peptidic hormone

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0500532A FR2880807B1 (en) 2005-01-19 2005-01-19 PHARMACEUTICAL COMPOSITION INJECTABLE

Publications (2)

Publication Number Publication Date
FR2880807A1 FR2880807A1 (en) 2006-07-21
FR2880807B1 true FR2880807B1 (en) 2007-04-13

Family

ID=34955408

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0500532A Expired - Fee Related FR2880807B1 (en) 2005-01-19 2005-01-19 PHARMACEUTICAL COMPOSITION INJECTABLE

Country Status (2)

Country Link
FR (1) FR2880807B1 (en)
WO (1) WO2006077309A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106061493A (en) * 2013-12-18 2016-10-26 乔治华盛顿大学国会特许非营利公司 Angiotensin ii alone or in combination for the treatment of hypotension
UY35988A (en) * 2014-02-27 2015-09-30 Sint Sa PROCESS FOR THE PRODUCTION OF AN INJECTABLE LOW CONCENTRATION NORADRENALINE SOLUTION
WO2019182745A1 (en) 2018-03-19 2019-09-26 Bryn Pharma, LLC Epinephrine spray formulations
CA3174640A1 (en) 2020-03-06 2021-09-10 Baxter International Inc. Packaged, sealed container system for stable storage of an oxygen sensitive pharmaceutical formulation

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5654278A (en) * 1994-10-13 1997-08-05 Novo Nordisk A/S Composition and method comprising growth hormone and leucine
US5827893A (en) * 1996-03-29 1998-10-27 Lurie; Keith G. Mechanical and pharmacological therapies to treat cardiac arrest
JPH10298102A (en) * 1997-04-25 1998-11-10 Taiyo Yakuhin Kogyo Kk Parenteral solution of calcitonin
JP2001233787A (en) * 2000-02-04 2001-08-28 Patents Exploitation Co Bv Small and medium size peptide-containing pharmaceutical compositions
FR2809619B1 (en) * 2000-06-06 2004-09-24 Pharmatop NOVEL AQUEOUS FORMULATIONS OF OXIDATION-SENSITIVE ACTIVE INGREDIENTS AND PROCESS FOR OBTAINING THEM
FR2832063B1 (en) * 2001-11-15 2004-08-27 Aguettant Lab PROCESS FOR PRODUCING STABLE SOLUTIONS OF PHENOLIC SUBSTANCES AND THE RESULTS THEREOF
ITMI20021684A1 (en) * 2002-07-29 2004-01-29 Therapicon Srl PHARMACEUTICAL COMPOSITION OF NASAL PEPTIDE

Also Published As

Publication number Publication date
FR2880807A1 (en) 2006-07-21
WO2006077309A1 (en) 2006-07-27

Similar Documents

Publication Publication Date Title
RU2398586C3 (en) PHARMACEUTICAL COMPOSITION
EP2191826A4 (en) PHARMACEUTICAL COMPOSITION
BRPI0715712A2 (en) PHARMACEUTICAL COMPOSITION
DK1940467T3 (en) Long-release drug composition
BRPI0511900A (en) pharmaceutical compositions
EP1982718A4 (en) ANTICANCER PHARMACEUTICAL COMPOSITION
BRPI0719393A2 (en) Pharmaceutical Composition
DK1962873T3 (en) PHARMACEUTICAL COMPOSITIONS INCLUDING OXALATE-REDUCING BACTERIA
DK2041139T3 (en) Pharmaceutical compounds
EP2025337A4 (en) EXTERNAL PHARMACEUTICAL COMPOSITION
DK1957073T3 (en) PHARMACEUTICAL
EP2005959A4 (en) EXTERNAL PHARMACEUTICAL COMPOSITION
EP2005958A4 (en) EXTERNAL PHARMACEUTICAL COMPOSITION
EP1962827A4 (en) PHARMACEUTICAL COMPOSITIONS OF COMBINATIONS OF DIPEPTIDYL-PEPTIDASE-4-INHIBITORS WITH METFORMIN
EP1871347A4 (en) PHARMACEUTICAL PREPARATION
BRPI0720234A2 (en) PHARMACEUTICAL COMPOSITION
BRPI0716445A2 (en) pharmaceutical composition
EP2191828A4 (en) ANTIFUNGAL PHARMACEUTICAL COMPOSITION
DE602006020744D1 (en) SYRINGE
EP1937255A4 (en) PHARMACEUTICAL COMPOSITION
BRPI0611748A2 (en) compound, pharmaceutical composition, and use of a pharmaceutical composition
EP1862184A4 (en) PHARMACEUTICAL COMPOSITION
MA28603B1 (en) ANTIMYCOBACTERIAL PHARMACEUTICAL COMPOSITION
EP2116241A4 (en) PHARMACEUTICAL COMPOSITION
BRPI0614413A2 (en) compound and pharmaceutical composition

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 12

PLFP Fee payment

Year of fee payment: 13

PLFP Fee payment

Year of fee payment: 14

ST Notification of lapse

Effective date: 20190906